Walleye Capital’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15K Sell
8,500
-229,300
-96% -$497K ﹤0.01% 4109
2025
Q4
$559K Buy
237,800
+230,500
+3,158% +$630K ﹤0.01% 2892
2025
Q3
$22.3K Sell
7,300
-4,000
-35% -$11.4K ﹤0.01% 4195
2025
Q2
$31.5K Sell
11,300
-700
-6% -$2.3K ﹤0.01% 4155
2025
Q1
$43.1K Sell
12,000
-3,600
-23% -$14.5K ﹤0.01% 3892
2024
Q4
$49.1K Buy
+15,600
New +$55.8K ﹤0.01% 4361

Other funds holding CLOV

Walleye Capital's CLOV Position: Q1 2026 in Review

Walleye Capital reduced its Clover Health Investments (CLOV) stake by 77% in Q1 2026, selling an estimated $179K and leaving 24,512 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3937.

Walleye Capital first reported a position in CLOV in Q2 2020 and has held it in 10 quarters since. The position peaked at $2.26M in Q2 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Walleye Capital held 24,512 shares of Clover Health Investments worth $43.1K as of Q1 2026.
  • Walleye Capital sold 82,689 Clover Health Investments shares in Q1 2026, an estimated $179K.
  • Clover Health Investments made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3937 holding.
  • Walleye Capital first reported a position in Clover Health Investments in Q2 2020 and has held it in 10 quarters since.
  • Walleye Capital's Clover Health Investments position peaked at $2.26M in Q2 2020.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.